Biopanda Drugs of Abuse Rapid Tests

October 11, 2019

Biopanda Drugs of Abuse Multi Rapid Tests. Cassette and Panel Tests can be manufactured for our customer's specific requirements. Choose from over 40 drugs of abuse.

Spotlight

Medicines for Europe

Medicines for Europe began over 20 years ago as the European Generics Medicines Association (EGA) with the goal of representing the emerging generic industry, and later growing to include biosimilar medicines to its portfolio. As the pharmaceutical industry and the healthcare environment within which it operates have evolved, so has our Association. When the association was first launched back in 1993, generic alternatives to branded medicines made up a fraction of the market. As more of these medicines came off-patent, and the benefits and value of generics to both patients and healthcare providers became clearer, so the provision of generic medicines has increased dramatically.

OTHER VIDEOS

Free flowing amorphous solid dispersions for enhanced drug solubility

video | March 9, 2022

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules....

Watch Now

Optimizing Outcomes Across the Pharma Value Chain Network

video | January 20, 2022

The pharma industry faces new challenges to be more agile and flexible in the effort to produce and deliver medicines to market faster. Digitalization will play a key role in helping companies optimize their value chain network. Hear from AspenTech's David Leitham as he touches on this trend and how Industrial AI solutions will help companies stay ahead....

Watch Now

How Billionaire Mark Cuban's Online Pharmacy Went From Pitch To Reality

video | February 2, 2022

Billionaire investor Mark Cuban launched an online pharmacy that offers more than 100 generic drugs at an affordable price with a goal of being “radically transparent” in its price negotiations with drug companies....

Watch Now

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

Spotlight

Medicines for Europe

Medicines for Europe began over 20 years ago as the European Generics Medicines Association (EGA) with the goal of representing the emerging generic industry, and later growing to include biosimilar medicines to its portfolio. As the pharmaceutical industry and the healthcare environment within which it operates have evolved, so has our Association. When the association was first launched back in 1993, generic alternatives to branded medicines made up a fraction of the market. As more of these medicines came off-patent, and the benefits and value of generics to both patients and healthcare providers became clearer, so the provision of generic medicines has increased dramatically.

Events